| 1 | 12-week | 2,807 |
| 2 | 4-week | 1,980 |
| 3 | 8-week | 1,697 |
| 4 | 6-week | 1,506 |
| 5 | 2-week | 1,311 |
| 6 | 7-day | 1,152 |
| 7 | 24-week | 847 |
| 8 | 3-day | 765 |
| 9 | 3-week | 712 |
| 10 | 1-week | 655 |
| 11 | 10-day | 587 |
| 12 | 14-day | 548 |
| 13 | 5-day | 512 |
| 14 | 16-week | 497 |
| 15 | 10-week | 475 |
| 16 | 30-min | 430 |
| 17 | 30-minute | 341 |
| 18 | 52-week | 295 |
| 19 | 21-day | 267 |
| 20 | two-week | 266 |
| 21 | 1-day | 254 |
| 22 | four-week | 233 |
| 23 | 26-week | 221 |
| 24 | 5-week | 221 |
| 25 | eight-week | 215 |
| 26 | six-week | 214 |
| 27 | 2-day | 211 |
| 28 | 48-week | 211 |
| 29 | 4-day | 209 |
| 30 | 15-min | 198 |
| 31 | 15-minute | 187 |
| 32 | one-week | 181 |
| 33 | seven-day | 170 |
| 34 | 10-minute | 167 |
| 35 | three-day | 155 |
| 36 | 20-minute | 146 |
| 37 | 9-week | 140 |
| 38 | 20-week | 136 |
| 39 | 12-wk | 132 |
| 40 | 4-wk | 125 |
| 41 | one-day | 121 |
| 42 | 15-day | 120 |
| 43 | 2-wk | 118 |
| 44 | 14-week | 116 |
| 45 | 7-week | 115 |
| 46 | three-week | 108 |
| 47 | two-dose | 103 |
| 48 | 8-wk | 99 |
| 49 | 13-week | 97 |
| 50 | two-month | 94 |
| 51 | 6-day | 91 |
| 52 | five-day | 88 |
| 53 | 8-hour | 86 |
| 54 | three-dose | 86 |
| 55 | 6-wk | 85 |
| 56 | 18-week | 81 |
| 57 | 8-h | 81 |
| 58 | 7-d | 79 |
| 59 | 3-wk | 75 |
| 60 | 2-phase | 74 |
| 61 | 96-week | 68 |
| 62 | two-day | 68 |
| 63 | 28-week | 67 |
| 64 | 8-day | 65 |
| 65 | 15-week | 63 |
| 66 | 36-week | 58 |
| 67 | 40-week | 55 |
| 68 | 14-d | 54 |
| 69 | 5-d | 54 |
| 70 | year-long | 53 |
| 71 | 10-d | 52 |
| 72 | 11-week | 52 |
| 73 | single-day | 52 |
| 74 | 28-d | 51 |
| 75 | ten-day | 47 |
| 76 | 10-wk | 46 |
| 77 | 4-d | 46 |
| 78 | 42-day | 43 |
| 79 | 12-day | 42 |
| 80 | four-day | 41 |
| 81 | 21-d | 39 |
| 82 | 32-week | 39 |
| 83 | 1-wk | 35 |
| 84 | 9-day | 35 |
| 85 | 30-week | 34 |
| 86 | 40-day | 34 |
| 87 | 24-wk | 33 |
| 88 | 20-day | 29 |
| 89 | five-week | 28 |
| 90 | 3-phase | 26 |
| 91 | week-long | 26 |
| 92 | 16-wk | 24 |
| 93 | 35-day | 24 |
| 94 | four-dose | 24 |
| 95 | 5-wk | 23 |
| 96 | dose-matched | 22 |
| 97 | 4-yr | 21 |
| 98 | 72-week | 21 |
| 99 | 17-week | 19 |
| 100 | nine-day | 19 |
| 101 | 22-week | 18 |
| 102 | 54-week | 18 |
| 103 | 56-week | 18 |
| 104 | single-treatment | 18 |
| 105 | ten-week | 17 |
| 106 | 16-day | 16 |
| 107 | 16-hour | 16 |
| 108 | 20-h | 16 |
| 109 | 25-minute | 16 |
| 110 | 25-week | 16 |
| 111 | 42-d | 16 |
| 112 | 56-day | 16 |
| 113 | 8-min | 16 |
| 114 | 15-session | 15 |
| 115 | multiple-day | 15 |
| 116 | yearlong | 15 |
| 117 | 4-mo | 14 |
| 118 | seven-month | 14 |
| 119 | 44-week | 13 |
| 120 | 10m | 12 |
| 121 | 20-hour | 12 |
| 122 | 30-hour | 12 |
| 123 | 60-week | 12 |
| 124 | month-long | 12 |
| 125 | 11-day | 11 |
| 126 | 21/7-day | 11 |
| 127 | 6-d | 11 |
| 128 | 84-day | 11 |
| 129 | eight-day | 11 |
| 130 | preintubation | 11 |
| 131 | 104-week | 10 |
| 132 | 15-d | 10 |
| 133 | 19-week | 10 |
| 134 | 22-day | 10 |
| 135 | 24/4-day | 10 |
| 136 | 5-days | 10 |
| 137 | 78-week | 10 |
| 138 | nine-week | 10 |
| 139 | six-hour | 10 |
| 140 | 52-wk | 9 |
| 141 | 76-week | 9 |
| 142 | 9-wk | 9 |
| 143 | three-center | 9 |
| 144 | 13-day | 8 |
| 145 | 18-day | 8 |
| 146 | 25-day | 8 |
| 147 | 27-week | 8 |
| 148 | 8-d | 8 |
| 149 | chemotherapy-free | 8 |
| 150 | cinacalcet-based | 8 |
| 151 | paraprofessional-delivered | 8 |
| 152 | six-day | 8 |
| 153 | ultra-rush | 8 |
| 154 | 2-4-week | 7 |
| 155 | 20-wk | 7 |
| 156 | 25-hour | 7 |
| 157 | 29-day | 7 |
| 158 | 30m | 7 |
| 159 | 48-wk | 7 |
| 160 | 56-d | 7 |
| 161 | 9-d | 7 |
| 162 | fairley | 7 |
| 163 | intravenous-to-oral | 7 |
| 164 | 12-d | 6 |
| 165 | 2-mo | 6 |
| 166 | 2-night | 6 |
| 167 | 26-wk | 6 |
| 168 | 36-hour | 6 |
| 169 | 40-h | 6 |
| 170 | 80-min | 6 |
| 171 | bortezomib-containing | 6 |
| 172 | chlorella-derived | 6 |
| 173 | gliclazide-mr-based | 6 |
| 174 | physical-therapy | 6 |
| 175 | 14-wk | 5 |
| 176 | 17-day | 5 |
| 177 | 34-week | 5 |
| 178 | 4-y | 5 |
| 179 | 5-mo | 5 |
| 180 | 7-10-day | 5 |
| 181 | 75-mg/day | 5 |
| 182 | control/no | 5 |
| 183 | daily-dosing | 5 |
| 184 | flavor-matched | 5 |
| 185 | hyper-energetic | 5 |
| 186 | multiple-breath | 5 |
| 187 | three-times-weekly | 5 |
| 188 | treat-and-extend | 5 |
| 189 | 1.5-h | 4 |
| 190 | 11-yr | 4 |
| 191 | 156-week | 4 |
| 192 | 18-wk | 4 |
| 193 | 19-day | 4 |
| 194 | 29-week | 4 |
| 195 | 3.5-week | 4 |
| 196 | 32-day | 4 |
| 197 | 33-week | 4 |
| 198 | 46-week | 4 |
| 199 | 47-week | 4 |
| 200 | 5-fraction | 4 |
| 201 | 60-hour | 4 |
| 202 | 7-14-day | 4 |
| 203 | 70-degree | 4 |
| 204 | 8-mo | 4 |
| 205 | 9-hour | 4 |
| 206 | 98-day | 4 |
| 207 | antenatal/intrapartum | 4 |
| 208 | custom-molded | 4 |
| 209 | post-occlusion | 4 |
| 210 | provegetarian | 4 |
| 211 | psychophysiologically | 4 |
| 212 | relapsing/remitting | 4 |
| 213 | split-dosage | 4 |
| 214 | stratified-care | 4 |
| 215 | three-time | 4 |
| 216 | two-cycle | 4 |
| 217 | variable-duration | 4 |
| 218 | vle | 4 |
| 219 | ≥45-day | 4 |
| 220 | 1-night | 3 |
| 221 | 11-d | 3 |
| 222 | 168-hour | 3 |
| 223 | 17-hour | 3 |
| 224 | 2-phased | 3 |
| 225 | 2.5-day | 3 |
| 226 | 23-week | 3 |
| 227 | 3-4-month | 3 |
| 228 | 30-mo | 3 |
| 229 | 40-d | 3 |
| 230 | 40-trial | 3 |
| 231 | 400-kcal | 3 |
| 232 | 48-d | 3 |
| 233 | 50-h | 3 |
| 234 | 500-m | 3 |
| 235 | 70-d | 3 |
| 236 | 8-week-long | 3 |
| 237 | 85-year | 3 |
| 238 | 9-weeks | 3 |
| 239 | 91-d | 3 |
| 240 | 93-d | 3 |
| 241 | 96-hr | 3 |
| 242 | carbohydrate-only | 3 |
| 243 | communicational | 3 |
| 244 | european/australian | 3 |
| 245 | insulin-only | 3 |
| 246 | inter-aortopulmonary | 3 |
| 247 | mtx-based | 3 |
| 248 | nontaxane | 3 |
| 249 | nucleate-boiling | 3 |
| 250 | nutritionist-led | 3 |
| 251 | paricalcitol-based | 3 |
| 252 | pill-splitting | 3 |
| 253 | quadruple-therapy | 3 |
| 254 | sulphonylurea-based | 3 |
| 255 | three-weeks | 3 |
| 256 | ≥7-day | 3 |
| 257 | 1-2-week | 2 |
| 258 | 10-12-day | 2 |
| 259 | 12.9-mm | 2 |
| 260 | 15-dose | 2 |
| 261 | 17-d | 2 |
| 262 | 2-3-week | 2 |
| 263 | 25-d | 2 |
| 264 | 25-h | 2 |
| 265 | 25-ms | 2 |
| 266 | 27-hour | 2 |
| 267 | 3-14-day | 2 |
| 268 | 3-4-week | 2 |
| 269 | 3-7-day | 2 |
| 270 | 3-day-long | 2 |
| 271 | 39day | 2 |
| 272 | 4-5-week | 2 |
| 273 | 40-mg/dl | 2 |
| 274 | 41-month | 2 |
| 275 | 47-min | 2 |
| 276 | 47-minute | 2 |
| 277 | 50-w | 2 |
| 278 | 71-month | 2 |
| 279 | 8-10-week | 2 |
| 280 | 8-night | 2 |
| 281 | 80-d | 2 |
| 282 | 86-year | 2 |
| 283 | atenolol±bendroflumethiazide-based | 2 |
| 284 | cardionet | 2 |
| 285 | concentric-concentric | 2 |
| 286 | csa-free | 2 |
| 287 | dacarbazine-based | 2 |
| 288 | day-averaged | 2 |
| 289 | fiber-only | 2 |
| 290 | fk506e-based | 2 |
| 291 | four-night | 2 |
| 292 | free-dose | 2 |
| 293 | game-themed | 2 |
| 294 | high-ropes | 2 |
| 295 | home-study | 2 |
| 296 | indinavir-containing | 2 |
| 297 | knee-exercise | 2 |
| 298 | lh-kit | 2 |
| 299 | metrical | 2 |
| 300 | multi-interventional | 2 |
| 301 | multitablet | 2 |
| 302 | open-group | 2 |
| 303 | or=4-week | 2 |
| 304 | pentoxifylline-matched | 2 |
| 305 | pharmacoclinical | 2 |
| 306 | pre-dose-averaged | 2 |
| 307 | prednisolone-matched | 2 |
| 308 | r-nimp | 2 |
| 309 | split-mixed | 2 |
| 310 | spring-driven | 2 |
| 311 | triple-inhaled | 2 |
| 312 | weight-stabilizing | 2 |
| 313 | 'clockwise | 1 |
| 314 | 'request | 1 |
| 315 | 0-3-week | 1 |
| 316 | 1,476-bp | 1 |
| 317 | 1,536-well | 1 |
| 318 | 1,647-bp | 1 |
| 319 | 1,956-bp | 1 |
| 320 | 1-4-week | 1 |
| 321 | 1-arm | 1 |
| 322 | 1-month-long | 1 |
| 323 | 105-hour | 1 |
| 324 | 12-dose | 1 |
| 325 | 130-hour | 1 |
| 326 | 1716-bp | 1 |
| 327 | 1734-bp | 1 |
| 328 | 19-cm-high | 1 |
| 329 | 1941-bp | 1 |
| 330 | 196-week | 1 |
| 331 | 2-12-week | 1 |
| 332 | 2-5-day | 1 |
| 333 | 2-5-week | 1 |
| 334 | 2-drugs | 1 |
| 335 | 2-week-long | 1 |
| 336 | 21-7-day | 1 |
| 337 | 2223-bp | 1 |
| 338 | 24+4-day | 1 |
| 339 | 24-4-day | 1 |
| 340 | 2631-bp | 1 |
| 341 | 275-bed | 1 |
| 342 | 3-time | 1 |
| 343 | 3-weelky | 1 |
| 344 | 30-dose | 1 |
| 345 | 303bp | 1 |
| 346 | 4-week-on/2-week-off | 1 |
| 347 | 456-bp | 1 |
| 348 | 5-10-day | 1 |
| 349 | 51-day | 1 |
| 350 | 52-hour | 1 |
| 351 | 57-residue | 1 |
| 352 | 6,10,14-week | 1 |
| 353 | 6-10-14-week | 1 |
| 354 | 6-10-week | 1 |
| 355 | 6-7-day | 1 |
| 356 | 600-mpa | 1 |
| 357 | 7-8-year | 1 |
| 358 | 708-bp | 1 |
| 359 | 83-year | 1 |
| 360 | 91-day | 1 |
| 361 | acidalkaline | 1 |
| 362 | apple-pectin-guar | 1 |
| 363 | aquatic-terrestrial | 1 |
| 364 | bedtime-treatment | 1 |
| 365 | boceprevir-containing | 1 |
| 366 | calorie-equivalent | 1 |
| 367 | cellwave | 1 |
| 368 | central-difference | 1 |
| 369 | centrally-set | 1 |
| 370 | chequer-board | 1 |
| 371 | chickens/dietary | 1 |
| 372 | chronic/indolent | 1 |
| 373 | client-directed | 1 |
| 374 | cni/mmf-maintenance | 1 |
| 375 | cognitive-restructuring | 1 |
| 376 | combimatrix | 1 |
| 377 | computer-managed | 1 |
| 378 | conventional/low-dose | 1 |
| 379 | counseling-based | 1 |
| 380 | cro-co | 1 |
| 381 | ctx-alone | 1 |
| 382 | cyclophosphamide-glucocorticoid | 1 |
| 383 | cyp3a/p-gp | 1 |
| 384 | dcv-containing | 1 |
| 385 | decreasing-dose | 1 |
| 386 | dehydration-acclimation | 1 |
| 387 | didanosine-based | 1 |
| 388 | dose-for-dose | 1 |
| 389 | double-blind/two | 1 |
| 390 | doubly-masked | 1 |
| 391 | dr-based | 1 |
| 392 | eight-h | 1 |
| 393 | eighty-year | 1 |
| 394 | extensively-used | 1 |
| 395 | faded-kr | 1 |
| 396 | femexam | 1 |
| 397 | first-induction | 1 |
| 398 | five-fraction | 1 |
| 399 | flavor/color/energy-matched | 1 |
| 400 | fluroquinolone-based | 1 |
| 401 | fourweek | 1 |
| 402 | fs-presbyopia | 1 |
| 403 | further-line | 1 |
| 404 | fusionless | 1 |
| 405 | haloperidol-based | 1 |
| 406 | heat-girdling | 1 |
| 407 | hepatopancreatobiliary-specific | 1 |
| 408 | her-2-oriented | 1 |
| 409 | histamine-type | 1 |
| 410 | human-interface | 1 |
| 411 | iii-v/si₃n₄ | 1 |
| 412 | iodometric | 1 |
| 413 | knee-randomised | 1 |
| 414 | lama-containing | 1 |
| 415 | logographic | 1 |
| 416 | long-access | 1 |
| 417 | macro-/micronutrient-matched | 1 |
| 418 | medcor | 1 |
| 419 | mercurimetric | 1 |
| 420 | merit-hf-defined | 1 |
| 421 | methodone | 1 |
| 422 | metoprolol-based | 1 |
| 423 | microfocusing | 1 |
| 424 | multi-medication | 1 |
| 425 | multiple-participant | 1 |
| 426 | mutimodal | 1 |
| 427 | nanowatt | 1 |
| 428 | non-advised | 1 |
| 429 | non-attachment-focused | 1 |
| 430 | non-cho | 1 |
| 431 | non-cinacalcet | 1 |
| 432 | non-sirolimus-based | 1 |
| 433 | non-trastuzumab-containing | 1 |
| 434 | nonablation | 1 |
| 435 | nonembodied | 1 |
| 436 | nonplacebo-controlled | 1 |
| 437 | nonplatinum-effective | 1 |
| 438 | nontapering | 1 |
| 439 | nonvibrating | 1 |
| 440 | nph-based | 1 |
| 441 | nsaid-free | 1 |
| 442 | one-credit-hour | 1 |
| 443 | pain-centred | 1 |
| 444 | period-by- | 1 |
| 445 | period-two | 1 |
| 446 | pharamcologic | 1 |
| 447 | phototherapy-only | 1 |
| 448 | pio-d144 | 1 |
| 449 | piranha | 1 |
| 450 | platinumcontaining | 1 |
| 451 | pre-decided | 1 |
| 452 | prefactsheet | 1 |
| 453 | prepayment | 1 |
| 454 | preventive-biomedical-psycho-social | 1 |
| 455 | prn-dosing | 1 |
| 456 | propofol/sevoflurane | 1 |
| 457 | pseudocoagulase | 1 |
| 458 | psychotherapeutic-type | 1 |
| 459 | quality-assessment | 1 |
| 460 | queen-size | 1 |
| 461 | radiation-alone | 1 |
| 462 | radiotherapy-dose | 1 |
| 463 | radiotherapy-plus-tmz | 1 |
| 464 | rate-of-dose | 1 |
| 465 | reinforcement-thinning | 1 |
| 466 | reminder/thank-you | 1 |
| 467 | renewable-based | 1 |
| 468 | respiratory-therapist | 1 |
| 469 | restricted-feeding | 1 |
| 470 | ribavirin-dosing | 1 |
| 471 | rifampin-based | 1 |
| 472 | rituximab-combined | 1 |
| 473 | safety/dose-confirming | 1 |
| 474 | screening/drug | 1 |
| 475 | semi-ambulatory | 1 |
| 476 | short-acyl-chain | 1 |
| 477 | sitagliptin-based | 1 |
| 478 | six-marker | 1 |
| 479 | speaker-specific | 1 |
| 480 | splenectomy-sparing | 1 |
| 481 | sponsor-issued | 1 |
| 482 | state-coding | 1 |
| 483 | strategy-learning-based | 1 |
| 484 | studious | 1 |
| 485 | sub-monolayer | 1 |
| 486 | subject-administered | 1 |
| 487 | submonolayer | 1 |
| 488 | substrate/biomass | 1 |
| 489 | subtarget | 1 |
| 490 | super-accelerated | 1 |
| 491 | synch-hcv | 1 |
| 492 | syncopated | 1 |
| 493 | tacrolimus/sirolimus/prednisone | 1 |
| 494 | tee-based | 1 |
| 495 | thoraco-brachial | 1 |
| 496 | three-modality | 1 |
| 497 | tic-specific | 1 |
| 498 | tipranavir-containing | 1 |
| 499 | tnrti-containing | 1 |
| 500 | to-7-day | 1 |
| 501 | topology-aware | 1 |
| 502 | treat-if-in-a | 1 |
| 503 | treatment-at-start-of-relapse | 1 |
| 504 | treatment/maintenance | 1 |
| 505 | two-course | 1 |
| 506 | uterine-preservation | 1 |
| 507 | variance-equivalent | 1 |
| 508 | vasopressin-containing | 1 |
| 509 | vchtv | 1 |
| 510 | video-delivered | 1 |
| 511 | vp16-based | 1 |
| 512 | washout/placebo | 1 |
| 513 | weekly-repeated | 1 |
| 514 | well-tracking | 1 |
| 515 | ≤12-week | 1 |
| 516 | ≥2-week | 1 |
| 517 | ≥21-day | 1 |
| 518 | ≥3-day | 1 |
| 519 | ≥348 | 1 |
| 520 | ≥5-day | 1 |
| 521 | ≥6-week | 1 |
| 522 | ⩾4-week | 1 |
| 1 | 'clockwise | 1 |
| 2 | 'request | 1 |
| 3 | 0-3-week | 1 |
| 4 | 1,476-bp | 1 |
| 5 | 1,536-well | 1 |
| 6 | 1,647-bp | 1 |
| 7 | 1,956-bp | 1 |
| 8 | 1-2-week | 2 |
| 9 | 1-4-week | 1 |
| 10 | 1-arm | 1 |
| 11 | 1-day | 254 |
| 12 | 1-month-long | 1 |
| 13 | 1-night | 3 |
| 14 | 1-week | 655 |
| 15 | 1-wk | 35 |
| 16 | 1.5-h | 4 |
| 17 | 10-12-day | 2 |
| 18 | 10-d | 52 |
| 19 | 10-day | 587 |
| 20 | 10-minute | 167 |
| 21 | 10-week | 475 |
| 22 | 10-wk | 46 |
| 23 | 104-week | 10 |
| 24 | 105-hour | 1 |
| 25 | 10m | 12 |
| 26 | 11-d | 3 |
| 27 | 11-day | 11 |
| 28 | 11-week | 52 |
| 29 | 11-yr | 4 |
| 30 | 12-d | 6 |
| 31 | 12-day | 42 |
| 32 | 12-dose | 1 |
| 33 | 12-week | 2,807 |
| 34 | 12-wk | 132 |
| 35 | 12.9-mm | 2 |
| 36 | 13-day | 8 |
| 37 | 13-week | 97 |
| 38 | 130-hour | 1 |
| 39 | 14-d | 54 |
| 40 | 14-day | 548 |
| 41 | 14-week | 116 |
| 42 | 14-wk | 5 |
| 43 | 15-d | 10 |
| 44 | 15-day | 120 |
| 45 | 15-dose | 2 |
| 46 | 15-min | 198 |
| 47 | 15-minute | 187 |
| 48 | 15-session | 15 |
| 49 | 15-week | 63 |
| 50 | 156-week | 4 |
| 51 | 16-day | 16 |
| 52 | 16-hour | 16 |
| 53 | 16-week | 497 |
| 54 | 16-wk | 24 |
| 55 | 168-hour | 3 |
| 56 | 17-d | 2 |
| 57 | 17-day | 5 |
| 58 | 17-hour | 3 |
| 59 | 17-week | 19 |
| 60 | 1716-bp | 1 |
| 61 | 1734-bp | 1 |
| 62 | 18-day | 8 |
| 63 | 18-week | 81 |
| 64 | 18-wk | 4 |
| 65 | 19-cm-high | 1 |
| 66 | 19-day | 4 |
| 67 | 19-week | 10 |
| 68 | 1941-bp | 1 |
| 69 | 196-week | 1 |
| 70 | 2-12-week | 1 |
| 71 | 2-3-week | 2 |
| 72 | 2-4-week | 7 |
| 73 | 2-5-day | 1 |
| 74 | 2-5-week | 1 |
| 75 | 2-day | 211 |
| 76 | 2-drugs | 1 |
| 77 | 2-mo | 6 |
| 78 | 2-night | 6 |
| 79 | 2-phase | 74 |
| 80 | 2-phased | 3 |
| 81 | 2-week | 1,311 |
| 82 | 2-week-long | 1 |
| 83 | 2-wk | 118 |
| 84 | 2.5-day | 3 |
| 85 | 20-day | 29 |
| 86 | 20-h | 16 |
| 87 | 20-hour | 12 |
| 88 | 20-minute | 146 |
| 89 | 20-week | 136 |
| 90 | 20-wk | 7 |
| 91 | 21-7-day | 1 |
| 92 | 21-d | 39 |
| 93 | 21-day | 267 |
| 94 | 21/7-day | 11 |
| 95 | 22-day | 10 |
| 96 | 22-week | 18 |
| 97 | 2223-bp | 1 |
| 98 | 23-week | 3 |
| 99 | 24+4-day | 1 |
| 100 | 24-4-day | 1 |
| 101 | 24-week | 847 |
| 102 | 24-wk | 33 |
| 103 | 24/4-day | 10 |
| 104 | 25-d | 2 |
| 105 | 25-day | 8 |
| 106 | 25-h | 2 |
| 107 | 25-hour | 7 |
| 108 | 25-minute | 16 |
| 109 | 25-ms | 2 |
| 110 | 25-week | 16 |
| 111 | 26-week | 221 |
| 112 | 26-wk | 6 |
| 113 | 2631-bp | 1 |
| 114 | 27-hour | 2 |
| 115 | 27-week | 8 |
| 116 | 275-bed | 1 |
| 117 | 28-d | 51 |
| 118 | 28-week | 67 |
| 119 | 29-day | 7 |
| 120 | 29-week | 4 |
| 121 | 3-14-day | 2 |
| 122 | 3-4-month | 3 |
| 123 | 3-4-week | 2 |
| 124 | 3-7-day | 2 |
| 125 | 3-day | 765 |
| 126 | 3-day-long | 2 |
| 127 | 3-phase | 26 |
| 128 | 3-time | 1 |
| 129 | 3-week | 712 |
| 130 | 3-weelky | 1 |
| 131 | 3-wk | 75 |
| 132 | 3.5-week | 4 |
| 133 | 30-dose | 1 |
| 134 | 30-hour | 12 |
| 135 | 30-min | 430 |
| 136 | 30-minute | 341 |
| 137 | 30-mo | 3 |
| 138 | 30-week | 34 |
| 139 | 303bp | 1 |
| 140 | 30m | 7 |
| 141 | 32-day | 4 |
| 142 | 32-week | 39 |
| 143 | 33-week | 4 |
| 144 | 34-week | 5 |
| 145 | 35-day | 24 |
| 146 | 36-hour | 6 |
| 147 | 36-week | 58 |
| 148 | 39day | 2 |
| 149 | 4-5-week | 2 |
| 150 | 4-d | 46 |
| 151 | 4-day | 209 |
| 152 | 4-mo | 14 |
| 153 | 4-week | 1,980 |
| 154 | 4-week-on/2-week-off | 1 |
| 155 | 4-wk | 125 |
| 156 | 4-y | 5 |
| 157 | 4-yr | 21 |
| 158 | 40-d | 3 |
| 159 | 40-day | 34 |
| 160 | 40-h | 6 |
| 161 | 40-mg/dl | 2 |
| 162 | 40-trial | 3 |
| 163 | 40-week | 55 |
| 164 | 400-kcal | 3 |
| 165 | 41-month | 2 |
| 166 | 42-d | 16 |
| 167 | 42-day | 43 |
| 168 | 44-week | 13 |
| 169 | 456-bp | 1 |
| 170 | 46-week | 4 |
| 171 | 47-min | 2 |
| 172 | 47-minute | 2 |
| 173 | 47-week | 4 |
| 174 | 48-d | 3 |
| 175 | 48-week | 211 |
| 176 | 48-wk | 7 |
| 177 | 5-10-day | 1 |
| 178 | 5-d | 54 |
| 179 | 5-day | 512 |
| 180 | 5-days | 10 |
| 181 | 5-fraction | 4 |
| 182 | 5-mo | 5 |
| 183 | 5-week | 221 |
| 184 | 5-wk | 23 |
| 185 | 50-h | 3 |
| 186 | 50-w | 2 |
| 187 | 500-m | 3 |
| 188 | 51-day | 1 |
| 189 | 52-hour | 1 |
| 190 | 52-week | 295 |
| 191 | 52-wk | 9 |
| 192 | 54-week | 18 |
| 193 | 56-d | 7 |
| 194 | 56-day | 16 |
| 195 | 56-week | 18 |
| 196 | 57-residue | 1 |
| 197 | 6,10,14-week | 1 |
| 198 | 6-10-14-week | 1 |
| 199 | 6-10-week | 1 |
| 200 | 6-7-day | 1 |
| 201 | 6-d | 11 |
| 202 | 6-day | 91 |
| 203 | 6-week | 1,506 |
| 204 | 6-wk | 85 |
| 205 | 60-hour | 4 |
| 206 | 60-week | 12 |
| 207 | 600-mpa | 1 |
| 208 | 7-10-day | 5 |
| 209 | 7-14-day | 4 |
| 210 | 7-8-year | 1 |
| 211 | 7-d | 79 |
| 212 | 7-day | 1,152 |
| 213 | 7-week | 115 |
| 214 | 70-d | 3 |
| 215 | 70-degree | 4 |
| 216 | 708-bp | 1 |
| 217 | 71-month | 2 |
| 218 | 72-week | 21 |
| 219 | 75-mg/day | 5 |
| 220 | 76-week | 9 |
| 221 | 78-week | 10 |
| 222 | 8-10-week | 2 |
| 223 | 8-d | 8 |
| 224 | 8-day | 65 |
| 225 | 8-h | 81 |
| 226 | 8-hour | 86 |
| 227 | 8-min | 16 |
| 228 | 8-mo | 4 |
| 229 | 8-night | 2 |
| 230 | 8-week | 1,697 |
| 231 | 8-week-long | 3 |
| 232 | 8-wk | 99 |
| 233 | 80-d | 2 |
| 234 | 80-min | 6 |
| 235 | 83-year | 1 |
| 236 | 84-day | 11 |
| 237 | 85-year | 3 |
| 238 | 86-year | 2 |
| 239 | 9-d | 7 |
| 240 | 9-day | 35 |
| 241 | 9-hour | 4 |
| 242 | 9-week | 140 |
| 243 | 9-weeks | 3 |
| 244 | 9-wk | 9 |
| 245 | 91-d | 3 |
| 246 | 91-day | 1 |
| 247 | 93-d | 3 |
| 248 | 96-hr | 3 |
| 249 | 96-week | 68 |
| 250 | 98-day | 4 |
| 251 | acidalkaline | 1 |
| 252 | antenatal/intrapartum | 4 |
| 253 | apple-pectin-guar | 1 |
| 254 | aquatic-terrestrial | 1 |
| 255 | atenolol±bendroflumethiazide-based | 2 |
| 256 | bedtime-treatment | 1 |
| 257 | boceprevir-containing | 1 |
| 258 | bortezomib-containing | 6 |
| 259 | calorie-equivalent | 1 |
| 260 | carbohydrate-only | 3 |
| 261 | cardionet | 2 |
| 262 | cellwave | 1 |
| 263 | central-difference | 1 |
| 264 | centrally-set | 1 |
| 265 | chemotherapy-free | 8 |
| 266 | chequer-board | 1 |
| 267 | chickens/dietary | 1 |
| 268 | chlorella-derived | 6 |
| 269 | chronic/indolent | 1 |
| 270 | cinacalcet-based | 8 |
| 271 | client-directed | 1 |
| 272 | cni/mmf-maintenance | 1 |
| 273 | cognitive-restructuring | 1 |
| 274 | combimatrix | 1 |
| 275 | communicational | 3 |
| 276 | computer-managed | 1 |
| 277 | concentric-concentric | 2 |
| 278 | control/no | 5 |
| 279 | conventional/low-dose | 1 |
| 280 | counseling-based | 1 |
| 281 | cro-co | 1 |
| 282 | csa-free | 2 |
| 283 | ctx-alone | 1 |
| 284 | custom-molded | 4 |
| 285 | cyclophosphamide-glucocorticoid | 1 |
| 286 | cyp3a/p-gp | 1 |
| 287 | dacarbazine-based | 2 |
| 288 | daily-dosing | 5 |
| 289 | day-averaged | 2 |
| 290 | dcv-containing | 1 |
| 291 | decreasing-dose | 1 |
| 292 | dehydration-acclimation | 1 |
| 293 | didanosine-based | 1 |
| 294 | dose-for-dose | 1 |
| 295 | dose-matched | 22 |
| 296 | double-blind/two | 1 |
| 297 | doubly-masked | 1 |
| 298 | dr-based | 1 |
| 299 | eight-day | 11 |
| 300 | eight-h | 1 |
| 301 | eight-week | 215 |
| 302 | eighty-year | 1 |
| 303 | european/australian | 3 |
| 304 | extensively-used | 1 |
| 305 | faded-kr | 1 |
| 306 | fairley | 7 |
| 307 | femexam | 1 |
| 308 | fiber-only | 2 |
| 309 | first-induction | 1 |
| 310 | five-day | 88 |
| 311 | five-fraction | 1 |
| 312 | five-week | 28 |
| 313 | fk506e-based | 2 |
| 314 | flavor-matched | 5 |
| 315 | flavor/color/energy-matched | 1 |
| 316 | fluroquinolone-based | 1 |
| 317 | four-day | 41 |
| 318 | four-dose | 24 |
| 319 | four-night | 2 |
| 320 | four-week | 233 |
| 321 | fourweek | 1 |
| 322 | free-dose | 2 |
| 323 | fs-presbyopia | 1 |
| 324 | further-line | 1 |
| 325 | fusionless | 1 |
| 326 | game-themed | 2 |
| 327 | gliclazide-mr-based | 6 |
| 328 | haloperidol-based | 1 |
| 329 | heat-girdling | 1 |
| 330 | hepatopancreatobiliary-specific | 1 |
| 331 | her-2-oriented | 1 |
| 332 | high-ropes | 2 |
| 333 | histamine-type | 1 |
| 334 | home-study | 2 |
| 335 | human-interface | 1 |
| 336 | hyper-energetic | 5 |
| 337 | iii-v/si₃n₄ | 1 |
| 338 | indinavir-containing | 2 |
| 339 | insulin-only | 3 |
| 340 | inter-aortopulmonary | 3 |
| 341 | intravenous-to-oral | 7 |
| 342 | iodometric | 1 |
| 343 | knee-exercise | 2 |
| 344 | knee-randomised | 1 |
| 345 | lama-containing | 1 |
| 346 | lh-kit | 2 |
| 347 | logographic | 1 |
| 348 | long-access | 1 |
| 349 | macro-/micronutrient-matched | 1 |
| 350 | medcor | 1 |
| 351 | mercurimetric | 1 |
| 352 | merit-hf-defined | 1 |
| 353 | methodone | 1 |
| 354 | metoprolol-based | 1 |
| 355 | metrical | 2 |
| 356 | microfocusing | 1 |
| 357 | month-long | 12 |
| 358 | mtx-based | 3 |
| 359 | multi-interventional | 2 |
| 360 | multi-medication | 1 |
| 361 | multiple-breath | 5 |
| 362 | multiple-day | 15 |
| 363 | multiple-participant | 1 |
| 364 | multitablet | 2 |
| 365 | mutimodal | 1 |
| 366 | nanowatt | 1 |
| 367 | nine-day | 19 |
| 368 | nine-week | 10 |
| 369 | non-advised | 1 |
| 370 | non-attachment-focused | 1 |
| 371 | non-cho | 1 |
| 372 | non-cinacalcet | 1 |
| 373 | non-sirolimus-based | 1 |
| 374 | non-trastuzumab-containing | 1 |
| 375 | nonablation | 1 |
| 376 | nonembodied | 1 |
| 377 | nonplacebo-controlled | 1 |
| 378 | nonplatinum-effective | 1 |
| 379 | nontapering | 1 |
| 380 | nontaxane | 3 |
| 381 | nonvibrating | 1 |
| 382 | nph-based | 1 |
| 383 | nsaid-free | 1 |
| 384 | nucleate-boiling | 3 |
| 385 | nutritionist-led | 3 |
| 386 | one-credit-hour | 1 |
| 387 | one-day | 121 |
| 388 | one-week | 181 |
| 389 | open-group | 2 |
| 390 | or=4-week | 2 |
| 391 | pain-centred | 1 |
| 392 | paraprofessional-delivered | 8 |
| 393 | paricalcitol-based | 3 |
| 394 | pentoxifylline-matched | 2 |
| 395 | period-by- | 1 |
| 396 | period-two | 1 |
| 397 | pharamcologic | 1 |
| 398 | pharmacoclinical | 2 |
| 399 | phototherapy-only | 1 |
| 400 | physical-therapy | 6 |
| 401 | pill-splitting | 3 |
| 402 | pio-d144 | 1 |
| 403 | piranha | 1 |
| 404 | platinumcontaining | 1 |
| 405 | post-occlusion | 4 |
| 406 | pre-decided | 1 |
| 407 | pre-dose-averaged | 2 |
| 408 | prednisolone-matched | 2 |
| 409 | prefactsheet | 1 |
| 410 | preintubation | 11 |
| 411 | prepayment | 1 |
| 412 | preventive-biomedical-psycho-social | 1 |
| 413 | prn-dosing | 1 |
| 414 | propofol/sevoflurane | 1 |
| 415 | provegetarian | 4 |
| 416 | pseudocoagulase | 1 |
| 417 | psychophysiologically | 4 |
| 418 | psychotherapeutic-type | 1 |
| 419 | quadruple-therapy | 3 |
| 420 | quality-assessment | 1 |
| 421 | queen-size | 1 |
| 422 | r-nimp | 2 |
| 423 | radiation-alone | 1 |
| 424 | radiotherapy-dose | 1 |
| 425 | radiotherapy-plus-tmz | 1 |
| 426 | rate-of-dose | 1 |
| 427 | reinforcement-thinning | 1 |
| 428 | relapsing/remitting | 4 |
| 429 | reminder/thank-you | 1 |
| 430 | renewable-based | 1 |
| 431 | respiratory-therapist | 1 |
| 432 | restricted-feeding | 1 |
| 433 | ribavirin-dosing | 1 |
| 434 | rifampin-based | 1 |
| 435 | rituximab-combined | 1 |
| 436 | safety/dose-confirming | 1 |
| 437 | screening/drug | 1 |
| 438 | semi-ambulatory | 1 |
| 439 | seven-day | 170 |
| 440 | seven-month | 14 |
| 441 | short-acyl-chain | 1 |
| 442 | single-day | 52 |
| 443 | single-treatment | 18 |
| 444 | sitagliptin-based | 1 |
| 445 | six-day | 8 |
| 446 | six-hour | 10 |
| 447 | six-marker | 1 |
| 448 | six-week | 214 |
| 449 | speaker-specific | 1 |
| 450 | splenectomy-sparing | 1 |
| 451 | split-dosage | 4 |
| 452 | split-mixed | 2 |
| 453 | sponsor-issued | 1 |
| 454 | spring-driven | 2 |
| 455 | state-coding | 1 |
| 456 | strategy-learning-based | 1 |
| 457 | stratified-care | 4 |
| 458 | studious | 1 |
| 459 | sub-monolayer | 1 |
| 460 | subject-administered | 1 |
| 461 | submonolayer | 1 |
| 462 | substrate/biomass | 1 |
| 463 | subtarget | 1 |
| 464 | sulphonylurea-based | 3 |
| 465 | super-accelerated | 1 |
| 466 | synch-hcv | 1 |
| 467 | syncopated | 1 |
| 468 | tacrolimus/sirolimus/prednisone | 1 |
| 469 | tee-based | 1 |
| 470 | ten-day | 47 |
| 471 | ten-week | 17 |
| 472 | thoraco-brachial | 1 |
| 473 | three-center | 9 |
| 474 | three-day | 155 |
| 475 | three-dose | 86 |
| 476 | three-modality | 1 |
| 477 | three-time | 4 |
| 478 | three-times-weekly | 5 |
| 479 | three-week | 108 |
| 480 | three-weeks | 3 |
| 481 | tic-specific | 1 |
| 482 | tipranavir-containing | 1 |
| 483 | tnrti-containing | 1 |
| 484 | to-7-day | 1 |
| 485 | topology-aware | 1 |
| 486 | treat-and-extend | 5 |
| 487 | treat-if-in-a | 1 |
| 488 | treatment-at-start-of-relapse | 1 |
| 489 | treatment/maintenance | 1 |
| 490 | triple-inhaled | 2 |
| 491 | two-course | 1 |
| 492 | two-cycle | 4 |
| 493 | two-day | 68 |
| 494 | two-dose | 103 |
| 495 | two-month | 94 |
| 496 | two-week | 266 |
| 497 | ultra-rush | 8 |
| 498 | uterine-preservation | 1 |
| 499 | variable-duration | 4 |
| 500 | variance-equivalent | 1 |
| 501 | vasopressin-containing | 1 |
| 502 | vchtv | 1 |
| 503 | video-delivered | 1 |
| 504 | vle | 4 |
| 505 | vp16-based | 1 |
| 506 | washout/placebo | 1 |
| 507 | week-long | 26 |
| 508 | weekly-repeated | 1 |
| 509 | weight-stabilizing | 2 |
| 510 | well-tracking | 1 |
| 511 | year-long | 53 |
| 512 | yearlong | 15 |
| 513 | ≤12-week | 1 |
| 514 | ≥2-week | 1 |
| 515 | ≥21-day | 1 |
| 516 | ≥3-day | 1 |
| 517 | ≥348 | 1 |
| 518 | ≥45-day | 4 |
| 519 | ≥5-day | 1 |
| 520 | ≥6-week | 1 |
| 521 | ≥7-day | 3 |
| 522 | ⩾4-week | 1 |
| 1 | period-by- | 1 |
| 2 | pio-d144 | 1 |
| 3 | ≥348 | 1 |
| 4 | treat-if-in-a | 1 |
| 5 | piranha | 1 |
| 6 | fs-presbyopia | 1 |
| 7 | 600-mpa | 1 |
| 8 | tic-specific | 1 |
| 9 | speaker-specific | 1 |
| 10 | hepatopancreatobiliary-specific | 1 |
| 11 | pharamcologic | 1 |
| 12 | logographic | 1 |
| 13 | mercurimetric | 1 |
| 14 | iodometric | 1 |
| 15 | concentric-concentric | 2 |
| 16 | hyper-energetic | 5 |
| 17 | 10-d | 52 |
| 18 | 40-d | 3 |
| 19 | 70-d | 3 |
| 20 | 80-d | 2 |
| 21 | 11-d | 3 |
| 22 | 21-d | 39 |
| 23 | 91-d | 3 |
| 24 | 12-d | 6 |
| 25 | 42-d | 16 |
| 26 | 93-d | 3 |
| 27 | 4-d | 46 |
| 28 | 14-d | 54 |
| 29 | 5-d | 54 |
| 30 | 15-d | 10 |
| 31 | 25-d | 2 |
| 32 | 6-d | 11 |
| 33 | 56-d | 7 |
| 34 | 7-d | 79 |
| 35 | 17-d | 2 |
| 36 | 8-d | 8 |
| 37 | 28-d | 51 |
| 38 | 48-d | 3 |
| 39 | 9-d | 7 |
| 40 | 275-bed | 1 |
| 41 | pre-decided | 1 |
| 42 | custom-molded | 4 |
| 43 | computer-managed | 1 |
| 44 | pre-dose-averaged | 2 |
| 45 | day-averaged | 2 |
| 46 | pentoxifylline-matched | 2 |
| 47 | prednisolone-matched | 2 |
| 48 | dose-matched | 22 |
| 49 | flavor-matched | 5 |
| 50 | macro-/micronutrient-matched | 1 |
| 51 | flavor/color/energy-matched | 1 |
| 52 | nonembodied | 1 |
| 53 | doubly-masked | 1 |
| 54 | nutritionist-led | 3 |
| 55 | triple-inhaled | 2 |
| 56 | nonplacebo-controlled | 1 |
| 57 | game-themed | 2 |
| 58 | rituximab-combined | 1 |
| 59 | merit-hf-defined | 1 |
| 60 | subject-administered | 1 |
| 61 | paraprofessional-delivered | 8 |
| 62 | video-delivered | 1 |
| 63 | pain-centred | 1 |
| 64 | vp16-based | 1 |
| 65 | sulphonylurea-based | 3 |
| 66 | fk506e-based | 2 |
| 67 | atenolol±bendroflumethiazide-based | 2 |
| 68 | tee-based | 1 |
| 69 | renewable-based | 1 |
| 70 | didanosine-based | 1 |
| 71 | dacarbazine-based | 2 |
| 72 | fluroquinolone-based | 1 |
| 73 | counseling-based | 1 |
| 74 | strategy-learning-based | 1 |
| 75 | nph-based | 1 |
| 76 | haloperidol-based | 1 |
| 77 | metoprolol-based | 1 |
| 78 | paricalcitol-based | 3 |
| 79 | rifampin-based | 1 |
| 80 | sitagliptin-based | 1 |
| 81 | dr-based | 1 |
| 82 | gliclazide-mr-based | 6 |
| 83 | non-sirolimus-based | 1 |
| 84 | cinacalcet-based | 8 |
| 85 | mtx-based | 3 |
| 86 | 2-phased | 3 |
| 87 | knee-randomised | 1 |
| 88 | non-advised | 1 |
| 89 | extensively-used | 1 |
| 90 | non-attachment-focused | 1 |
| 91 | weekly-repeated | 1 |
| 92 | syncopated | 1 |
| 93 | super-accelerated | 1 |
| 94 | client-directed | 1 |
| 95 | her-2-oriented | 1 |
| 96 | sponsor-issued | 1 |
| 97 | chlorella-derived | 6 |
| 98 | split-mixed | 2 |
| 99 | cyclophosphamide-glucocorticoid | 1 |
| 100 | treat-and-extend | 5 |
| 101 | chequer-board | 1 |
| 102 | human-interface | 1 |
| 103 | cni/mmf-maintenance | 1 |
| 104 | treatment/maintenance | 1 |
| 105 | central-difference | 1 |
| 106 | csa-free | 2 |
| 107 | nsaid-free | 1 |
| 108 | chemotherapy-free | 8 |
| 109 | 70-degree | 4 |
| 110 | split-dosage | 4 |
| 111 | two-cycle | 4 |
| 112 | vle | 4 |
| 113 | 3-time | 1 |
| 114 | three-time | 4 |
| 115 | propofol/sevoflurane | 1 |
| 116 | nontaxane | 3 |
| 117 | further-line | 1 |
| 118 | acidalkaline | 1 |
| 119 | methodone | 1 |
| 120 | radiation-alone | 1 |
| 121 | ctx-alone | 1 |
| 122 | tacrolimus/sirolimus/prednisone | 1 |
| 123 | psychotherapeutic-type | 1 |
| 124 | histamine-type | 1 |
| 125 | stratified-care | 4 |
| 126 | topology-aware | 1 |
| 127 | 2-phase | 74 |
| 128 | 3-phase | 26 |
| 129 | pseudocoagulase | 1 |
| 130 | knee-exercise | 2 |
| 131 | 'clockwise | 1 |
| 132 | 30-dose | 1 |
| 133 | 12-dose | 1 |
| 134 | 15-dose | 2 |
| 135 | free-dose | 2 |
| 136 | three-dose | 86 |
| 137 | rate-of-dose | 1 |
| 138 | decreasing-dose | 1 |
| 139 | two-dose | 103 |
| 140 | dose-for-dose | 1 |
| 141 | four-dose | 24 |
| 142 | conventional/low-dose | 1 |
| 143 | radiotherapy-dose | 1 |
| 144 | treatment-at-start-of-relapse | 1 |
| 145 | two-course | 1 |
| 146 | 10-minute | 167 |
| 147 | 20-minute | 146 |
| 148 | 30-minute | 341 |
| 149 | 15-minute | 187 |
| 150 | 25-minute | 16 |
| 151 | 47-minute | 2 |
| 152 | 57-residue | 1 |
| 153 | cellwave | 1 |
| 154 | nonplatinum-effective | 1 |
| 155 | queen-size | 1 |
| 156 | 4-week-on/2-week-off | 1 |
| 157 | restricted-feeding | 1 |
| 158 | state-coding | 1 |
| 159 | well-tracking | 1 |
| 160 | heat-girdling | 1 |
| 161 | nucleate-boiling | 3 |
| 162 | safety/dose-confirming | 1 |
| 163 | lama-containing | 1 |
| 164 | non-trastuzumab-containing | 1 |
| 165 | bortezomib-containing | 6 |
| 166 | tnrti-containing | 1 |
| 167 | vasopressin-containing | 1 |
| 168 | tipranavir-containing | 1 |
| 169 | indinavir-containing | 2 |
| 170 | boceprevir-containing | 1 |
| 171 | dcv-containing | 1 |
| 172 | platinumcontaining | 1 |
| 173 | reinforcement-thinning | 1 |
| 174 | splenectomy-sparing | 1 |
| 175 | nontapering | 1 |
| 176 | cognitive-restructuring | 1 |
| 177 | ribavirin-dosing | 1 |
| 178 | prn-dosing | 1 |
| 179 | daily-dosing | 5 |
| 180 | microfocusing | 1 |
| 181 | nonvibrating | 1 |
| 182 | pill-splitting | 3 |
| 183 | relapsing/remitting | 4 |
| 184 | weight-stabilizing | 2 |
| 185 | month-long | 12 |
| 186 | 1-month-long | 1 |
| 187 | week-long | 26 |
| 188 | 2-week-long | 1 |
| 189 | 8-week-long | 3 |
| 190 | year-long | 53 |
| 191 | 3-day-long | 2 |
| 192 | yearlong | 15 |
| 193 | screening/drug | 1 |
| 194 | 20-h | 16 |
| 195 | 40-h | 6 |
| 196 | 50-h | 3 |
| 197 | 1.5-h | 4 |
| 198 | 25-h | 2 |
| 199 | 8-h | 81 |
| 200 | eight-h | 1 |
| 201 | 19-cm-high | 1 |
| 202 | ultra-rush | 8 |
| 203 | multiple-breath | 5 |
| 204 | 41-month | 2 |
| 205 | 71-month | 2 |
| 206 | 3-4-month | 3 |
| 207 | seven-month | 14 |
| 208 | two-month | 94 |
| 209 | 10-week | 475 |
| 210 | 6-10-week | 1 |
| 211 | 8-10-week | 2 |
| 212 | 20-week | 136 |
| 213 | 30-week | 34 |
| 214 | 40-week | 55 |
| 215 | 60-week | 12 |
| 216 | 1-week | 655 |
| 217 | 11-week | 52 |
| 218 | 2-week | 1,311 |
| 219 | 1-2-week | 2 |
| 220 | 12-week | 2,807 |
| 221 | 2-12-week | 1 |
| 222 | ≤12-week | 1 |
| 223 | 22-week | 18 |
| 224 | 32-week | 39 |
| 225 | 52-week | 295 |
| 226 | 72-week | 21 |
| 227 | ≥2-week | 1 |
| 228 | 3-week | 712 |
| 229 | 0-3-week | 1 |
| 230 | 2-3-week | 2 |
| 231 | 13-week | 97 |
| 232 | 23-week | 3 |
| 233 | 33-week | 4 |
| 234 | 4-week | 1,980 |
| 235 | 1-4-week | 1 |
| 236 | 2-4-week | 7 |
| 237 | 3-4-week | 2 |
| 238 | 104-week | 10 |
| 239 | 14-week | 116 |
| 240 | 6,10,14-week | 1 |
| 241 | 6-10-14-week | 1 |
| 242 | 24-week | 847 |
| 243 | 34-week | 5 |
| 244 | 44-week | 13 |
| 245 | 54-week | 18 |
| 246 | or=4-week | 2 |
| 247 | ⩾4-week | 1 |
| 248 | 5-week | 221 |
| 249 | 2-5-week | 1 |
| 250 | 4-5-week | 2 |
| 251 | 3.5-week | 4 |
| 252 | 15-week | 63 |
| 253 | 25-week | 16 |
| 254 | 6-week | 1,506 |
| 255 | 16-week | 497 |
| 256 | 26-week | 221 |
| 257 | 36-week | 58 |
| 258 | 46-week | 4 |
| 259 | 56-week | 18 |
| 260 | 156-week | 4 |
| 261 | 76-week | 9 |
| 262 | 96-week | 68 |
| 263 | 196-week | 1 |
| 264 | ≥6-week | 1 |
| 265 | 7-week | 115 |
| 266 | 17-week | 19 |
| 267 | 27-week | 8 |
| 268 | 47-week | 4 |
| 269 | 8-week | 1,697 |
| 270 | 18-week | 81 |
| 271 | 28-week | 67 |
| 272 | 48-week | 211 |
| 273 | 78-week | 10 |
| 274 | 9-week | 140 |
| 275 | 19-week | 10 |
| 276 | 29-week | 4 |
| 277 | three-week | 108 |
| 278 | nine-week | 10 |
| 279 | one-week | 181 |
| 280 | five-week | 28 |
| 281 | ten-week | 17 |
| 282 | two-week | 266 |
| 283 | four-week | 233 |
| 284 | eight-week | 215 |
| 285 | six-week | 214 |
| 286 | fourweek | 1 |
| 287 | 10-wk | 46 |
| 288 | 20-wk | 7 |
| 289 | 1-wk | 35 |
| 290 | 2-wk | 118 |
| 291 | 12-wk | 132 |
| 292 | 52-wk | 9 |
| 293 | 3-wk | 75 |
| 294 | 4-wk | 125 |
| 295 | 14-wk | 5 |
| 296 | 24-wk | 33 |
| 297 | 5-wk | 23 |
| 298 | 6-wk | 85 |
| 299 | 16-wk | 24 |
| 300 | 26-wk | 6 |
| 301 | 8-wk | 99 |
| 302 | 18-wk | 4 |
| 303 | 48-wk | 7 |
| 304 | 9-wk | 9 |
| 305 | pharmacoclinical | 2 |
| 306 | metrical | 2 |
| 307 | 400-kcal | 3 |
| 308 | mutimodal | 1 |
| 309 | preventive-biomedical-psycho-social | 1 |
| 310 | thoraco-brachial | 1 |
| 311 | 40-trial | 3 |
| 312 | aquatic-terrestrial | 1 |
| 313 | communicational | 3 |
| 314 | multi-interventional | 2 |
| 315 | intravenous-to-oral | 7 |
| 316 | 40-mg/dl | 2 |
| 317 | 1,536-well | 1 |
| 318 | 500-m | 3 |
| 319 | 10m | 12 |
| 320 | 30m | 7 |
| 321 | femexam | 1 |
| 322 | 12.9-mm | 2 |
| 323 | 1-arm | 1 |
| 324 | antenatal/intrapartum | 4 |
| 325 | european/australian | 3 |
| 326 | provegetarian | 4 |
| 327 | spring-driven | 2 |
| 328 | short-acyl-chain | 1 |
| 329 | 30-min | 430 |
| 330 | 80-min | 6 |
| 331 | 15-min | 198 |
| 332 | 47-min | 2 |
| 333 | 8-min | 16 |
| 334 | 15-session | 15 |
| 335 | post-occlusion | 4 |
| 336 | preintubation | 11 |
| 337 | multi-medication | 1 |
| 338 | nonablation | 1 |
| 339 | dehydration-acclimation | 1 |
| 340 | variable-duration | 4 |
| 341 | uterine-preservation | 1 |
| 342 | 5-fraction | 4 |
| 343 | five-fraction | 1 |
| 344 | first-induction | 1 |
| 345 | washout/placebo | 1 |
| 346 | cro-co | 1 |
| 347 | non-cho | 1 |
| 348 | 30-mo | 3 |
| 349 | 2-mo | 6 |
| 350 | 4-mo | 14 |
| 351 | 5-mo | 5 |
| 352 | 8-mo | 4 |
| 353 | control/no | 5 |
| 354 | period-two | 1 |
| 355 | double-blind/two | 1 |
| 356 | 2631-bp | 1 |
| 357 | 1941-bp | 1 |
| 358 | 2223-bp | 1 |
| 359 | 1734-bp | 1 |
| 360 | 1716-bp | 1 |
| 361 | 456-bp | 1 |
| 362 | 1,956-bp | 1 |
| 363 | 1,476-bp | 1 |
| 364 | 1,647-bp | 1 |
| 365 | 708-bp | 1 |
| 366 | 303bp | 1 |
| 367 | cyp3a/p-gp | 1 |
| 368 | r-nimp | 2 |
| 369 | open-group | 2 |
| 370 | 83-year | 1 |
| 371 | 85-year | 3 |
| 372 | 86-year | 2 |
| 373 | 7-8-year | 1 |
| 374 | eighty-year | 1 |
| 375 | apple-pectin-guar | 1 |
| 376 | six-marker | 1 |
| 377 | three-center | 9 |
| 378 | sub-monolayer | 1 |
| 379 | submonolayer | 1 |
| 380 | 96-hr | 3 |
| 381 | faded-kr | 1 |
| 382 | medcor | 1 |
| 383 | 20-hour | 12 |
| 384 | 30-hour | 12 |
| 385 | 130-hour | 1 |
| 386 | 60-hour | 4 |
| 387 | 52-hour | 1 |
| 388 | 105-hour | 1 |
| 389 | 25-hour | 7 |
| 390 | 16-hour | 16 |
| 391 | 36-hour | 6 |
| 392 | 17-hour | 3 |
| 393 | 27-hour | 2 |
| 394 | 8-hour | 86 |
| 395 | 168-hour | 3 |
| 396 | 9-hour | 4 |
| 397 | one-credit-hour | 1 |
| 398 | six-hour | 10 |
| 399 | 11-yr | 4 |
| 400 | 4-yr | 21 |
| 401 | high-ropes | 2 |
| 402 | 2-drugs | 1 |
| 403 | 9-weeks | 3 |
| 404 | three-weeks | 3 |
| 405 | 25-ms | 2 |
| 406 | substrate/biomass | 1 |
| 407 | long-access | 1 |
| 408 | fusionless | 1 |
| 409 | studious | 1 |
| 410 | 5-days | 10 |
| 411 | non-cinacalcet | 1 |
| 412 | prefactsheet | 1 |
| 413 | subtarget | 1 |
| 414 | multitablet | 2 |
| 415 | cardionet | 2 |
| 416 | centrally-set | 1 |
| 417 | 1-night | 3 |
| 418 | 2-night | 6 |
| 419 | 8-night | 2 |
| 420 | four-night | 2 |
| 421 | lh-kit | 2 |
| 422 | multiple-participant | 1 |
| 423 | variance-equivalent | 1 |
| 424 | calorie-equivalent | 1 |
| 425 | chronic/indolent | 1 |
| 426 | quality-assessment | 1 |
| 427 | single-treatment | 18 |
| 428 | bedtime-treatment | 1 |
| 429 | prepayment | 1 |
| 430 | 'request | 1 |
| 431 | respiratory-therapist | 1 |
| 432 | nanowatt | 1 |
| 433 | reminder/thank-you | 1 |
| 434 | synch-hcv | 1 |
| 435 | vchtv | 1 |
| 436 | 50-w | 2 |
| 437 | combimatrix | 1 |
| 438 | 4-y | 5 |
| 439 | 10-day | 587 |
| 440 | 5-10-day | 1 |
| 441 | 7-10-day | 5 |
| 442 | 20-day | 29 |
| 443 | 40-day | 34 |
| 444 | 1-day | 254 |
| 445 | 11-day | 11 |
| 446 | 21-day | 267 |
| 447 | ≥21-day | 1 |
| 448 | 51-day | 1 |
| 449 | 91-day | 1 |
| 450 | 2-day | 211 |
| 451 | 12-day | 42 |
| 452 | 10-12-day | 2 |
| 453 | 22-day | 10 |
| 454 | 32-day | 4 |
| 455 | 42-day | 43 |
| 456 | 3-day | 765 |
| 457 | 13-day | 8 |
| 458 | ≥3-day | 1 |
| 459 | 4-day | 209 |
| 460 | 24+4-day | 1 |
| 461 | 24-4-day | 1 |
| 462 | 24/4-day | 10 |
| 463 | 14-day | 548 |
| 464 | 3-14-day | 2 |
| 465 | 7-14-day | 4 |
| 466 | 84-day | 11 |
| 467 | 5-day | 512 |
| 468 | 2-5-day | 1 |
| 469 | 2.5-day | 3 |
| 470 | 15-day | 120 |
| 471 | 25-day | 8 |
| 472 | 35-day | 24 |
| 473 | ≥45-day | 4 |
| 474 | ≥5-day | 1 |
| 475 | 6-day | 91 |
| 476 | 16-day | 16 |
| 477 | 56-day | 16 |
| 478 | 7-day | 1,152 |
| 479 | 21-7-day | 1 |
| 480 | 3-7-day | 2 |
| 481 | 6-7-day | 1 |
| 482 | to-7-day | 1 |
| 483 | 21/7-day | 11 |
| 484 | 17-day | 5 |
| 485 | ≥7-day | 3 |
| 486 | 8-day | 65 |
| 487 | 18-day | 8 |
| 488 | 98-day | 4 |
| 489 | 9-day | 35 |
| 490 | 19-day | 4 |
| 491 | 29-day | 7 |
| 492 | three-day | 155 |
| 493 | single-day | 52 |
| 494 | multiple-day | 15 |
| 495 | nine-day | 19 |
| 496 | one-day | 121 |
| 497 | five-day | 88 |
| 498 | ten-day | 47 |
| 499 | seven-day | 170 |
| 500 | two-day | 68 |
| 501 | four-day | 41 |
| 502 | eight-day | 11 |
| 503 | six-day | 8 |
| 504 | 75-mg/day | 5 |
| 505 | 39day | 2 |
| 506 | home-study | 2 |
| 507 | fairley | 7 |
| 508 | 3-weelky | 1 |
| 509 | three-times-weekly | 5 |
| 510 | psychophysiologically | 4 |
| 511 | carbohydrate-only | 3 |
| 512 | insulin-only | 3 |
| 513 | fiber-only | 2 |
| 514 | phototherapy-only | 1 |
| 515 | quadruple-therapy | 3 |
| 516 | physical-therapy | 6 |
| 517 | inter-aortopulmonary | 3 |
| 518 | chickens/dietary | 1 |
| 519 | semi-ambulatory | 1 |
| 520 | three-modality | 1 |
| 521 | radiotherapy-plus-tmz | 1 |
| 522 | iii-v/si₃n₄ | 1 |